Skip Navigation
  • Text Size: A A A
  • Print
  • Email
  • Facebook
  • Tweet
  • Share
  • Print
  • Email
  • Facebook
  • Tweet
  • Share

SACHRP Recommendations by Date

SACHRP advisory documents are the result of considerable Committee effort, deliberation and consensus building. Once the Committee achieves consensus on an issue, its recommendations are posted on this website and transmitted by the Chair to the Secretary of Health and Human Services, Assistant Secretary for Health, and to the Director of OHRP for their consideration.  The content of these documents is advisory and does not represent the official views or policies of OHRP or the Department of Health and Human Services.

25. (To be posted) SACHRP Letter to the Secretary 

Attachment A: Big Data and the Impact on Human Subjects Research

Attachment B: Commentary on FDA Draft Guidance, “General Clinical Pharmacology Considerations for Pediatric Studies for Drugs and Biological  Products,”   released December 9, 2014, docket number FDA-2013-D-1275-0002 

Attachment C: Commentary on FDA Draft Guidance, “Use of Electronic Informed Consent in Clinical Investigations, Questions and Answers, Guidance for Industry,”  released March 9, 2015, docket number FDA-2015-D-0390-0002

Attachment D: Recommendations Regarding Return of General Research Results

Attachment E: Recommendations Regarding Research Uses of Newborn Dried Bloodspots and the Newborn Screening Saves Lives Reauthorization Act of 2014    

Attachment F: Recommendations Regarding the Draft NIH Policy on the Use of a Single Institutional Review Board for Multi-site Research


Content last reviewed on August 19, 2014